Johnson Pharmacare Limited

BSE:532154 Stock Report

Market Cap: ₹627.0m

Johnson Pharmacare Past Earnings Performance

Past criteria checks 0/6

Johnson Pharmacare's earnings have been declining at an average annual rate of -38.9%, while the Trade Distributors industry saw earnings growing at 28.8% annually. Revenues have been declining at an average rate of 0.6% per year.

Key information

-38.9%

Earnings growth rate

-50.6%

EPS growth rate

Trade Distributors Industry Growth27.3%
Revenue growth rate-0.6%
Return on equity-0.08%
Net Marginn/a
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Johnson Pharmacare makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BSE:532154 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 240000
30 Jun 240000
31 Mar 240-200
31 Dec 2315-300
30 Sep 230-1800
30 Jun 230-1900
31 Mar 2325-1310
31 Dec 2210-1610
30 Sep 2226020
30 Jun 2243320
31 Mar 2233110
31 Dec 2140600
30 Sep 2140500
30 Jun 2123200
31 Mar 218000
31 Dec 200-200
30 Sep 200-100
30 Jun 200-100
31 Mar 200-100
31 Dec 194000
30 Sep 199000
30 Jun 199000
31 Mar 199000
31 Dec 186000
30 Sep 180-100
30 Jun 180-100
31 Mar 180-100
31 Dec 170-110
30 Sep 170-110
30 Jun 170-110
31 Mar 170-100
31 Dec 160200
30 Sep 160-100
30 Jun 160-100
31 Mar 160-110
31 Dec 150-400
30 Sep 150000
30 Jun 150-100
31 Mar 150-100
31 Dec 148,493-410
30 Sep 1410,012-710
30 Jun 1416,808100
31 Mar 1417,910-110
31 Dec 1310,134300

Quality Earnings: 532154 is currently unprofitable.

Growing Profit Margin: 532154 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 532154 is unprofitable, and losses have increased over the past 5 years at a rate of 38.9% per year.

Accelerating Growth: Unable to compare 532154's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 532154 is unprofitable, making it difficult to compare its past year earnings growth to the Trade Distributors industry (22.7%).


Return on Equity

High ROE: 532154 has a negative Return on Equity (-0.083%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 22:12
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Johnson Pharmacare Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution